Supply of Norgestimate and Ethinyl Estradiol Tablets

This subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the supply of FDA-regulated Norgestimate and Ethinyl Estradiol tablets to support prime contractors delivering DLA supply contracts. The selected provider must manufacture or source the pharmaceutical compound and package the tablets into units of six cycles, totaling 168 tablets per unit, while adhering to Medical Marking Standard No. 1. A total delivery of 1,000 PG of tablets is required. The contractor must utilize FDA-approved manufacturing facilities and maintain full compliance with all FDA regulations governing prescription medications. Performance for this contract will take place at Fort Drum, New York. The solicitation was posted on September 2, 2026, with a response deadline of September 8, 2026, under NAICS code 325412.